Page last updated: 2024-08-24

aripiprazole and Atherosclerotic Parkinsonism

aripiprazole has been researched along with Atherosclerotic Parkinsonism in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's9 (90.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Chakrabarti, SS; Gambhir, IS; Kaur, U; Ojha, B; Pathak, BK; Singh, A1
Blumberger, DM; Hsu, JH; Karp, JF; Lenze, EJ; Mulsant, BH; Reynolds, CF; Sanches, M1
Belletti, A; Cilia, R; Marotta, G; Pezzoli, G; Siri, C1
Al-Jadiri, A; Azzo, S; Carbon, M; Correll, CU; Kane, JM; Kapoor, S; Saito, E; Sarkaria, T; Sheridan, E1
Anderson, SJ; Begley, AE; Blumberger, DM; Butters, MA; Dew, MA; Karp, JF; Lenze, EJ; Mulsant, BH; Newcomer, JW; Reynolds, CF; Stack, JA1
Chen, YW; Tseng, PT1
Chouinard, S; Huot, P; Selfani, K; Soland, VL1
Albayrak, Y; Caykoylu, A; Ekinci, O; Ugurlu, GK1
Ishitobi, M; Kosaka, H; Murata, T; Oonuma, M; Takahashi, T; Wada, Y1
Miranda C, M; Retamal C, P1

Reviews

1 review(s) available for aripiprazole and Atherosclerotic Parkinsonism

ArticleYear
A Review of Differences in Clinical Characteristics between Tardive Syndrome Induced or Improved by Aripiprazole Treatment.
    Acta neurologica Taiwanica, 2016, Sep-15, Volume: 25, Issue:3

    Topics: Antipsychotic Agents; Aripiprazole; Dystonia; Humans; Parkinson Disease, Secondary; Psychotic Disorders; Tardive Dyskinesia

2016

Trials

2 trial(s) available for aripiprazole and Atherosclerotic Parkinsonism

ArticleYear
Clinical Predictors of Extrapyramidal Symptoms Associated With Aripiprazole Augmentation for the Treatment of Late-Life Depression in a Randomized Controlled Trial.
    The Journal of clinical psychiatry, 2018, 06-19, Volume: 79, Issue:4

    Topics: Aged; Akathisia, Drug-Induced; Antidepressive Agents; Aripiprazole; Depressive Disorder, Treatment-Resistant; Female; Humans; Late Onset Disorders; Male; Parkinson Disease, Secondary; Risk Factors; Time Factors

2018
Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial.
    Lancet (London, England), 2015, Dec-12, Volume: 386, Issue:10011

    Topics: Aged; Akathisia, Drug-Induced; Antidepressive Agents; Aripiprazole; Depressive Disorder, Treatment-Resistant; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Recurrence; Treatment Outcome

2015

Other Studies

7 other study(ies) available for aripiprazole and Atherosclerotic Parkinsonism

ArticleYear
Aripiprazole-induced Parkinsonism with pregabalin as a confounder.
    Acta neurologica Belgica, 2021, Volume: 121, Issue:5

    Topics: Antipsychotic Agents; Aripiprazole; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Pregabalin

2021
Reversible dopamine transporter reduction in drug-induced Parkinsonism.
    Movement disorders : official journal of the Movement Disorder Society, 2014, Volume: 29, Issue:4

    Topics: Aged; Aripiprazole; Bipolar Disorder; Brain; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Lithium Carbonate; Parkinson Disease, Secondary; Piperazines; Quinolones; Radionuclide Imaging

2014
Neuromotor Adverse Effects in 342 Youth During 12 Weeks of Naturalistic Treatment With 5 Second-Generation Antipsychotics.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2015, Volume: 54, Issue:9

    Topics: Adolescent; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Male; Mental Disorders; Multivariate Analysis; New York; Olanzapine; Parkinson Disease, Secondary; Piperazines; Prospective Studies; Quetiapine Fumarate; Regression Analysis; Risperidone; Thiazoles

2015
Movement Disorders Induced by the "Atypical" Antipsychotic Aripiprazole.
    The neurologist, 2017, Volume: 22, Issue:1

    Topics: Adult; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Female; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Tardive Dyskinesia; Young Adult

2017
Aripiprazole-associated bruxism, akathisia, and parkinsonism in a bipolar patient.
    Journal of clinical psychopharmacology, 2011, Volume: 31, Issue:1

    Topics: Akathisia, Drug-Induced; Aripiprazole; Bipolar Disorder; Bruxism; Female; Humans; Parkinson Disease, Secondary; Piperazines; Quinolones; Young Adult

2011
Aripiprazole monotherapy in the treatment of vascular parkinsonism.
    Psychiatry and clinical neurosciences, 2011, Volume: 65, Issue:6

    Topics: Aged; Antipsychotic Agents; Aripiprazole; Female; Humans; Parkinson Disease, Secondary; Piperazines; Psychotic Disorders; Quinolones; Treatment Outcome

2011
[Potentiation of Aripiprazole extrapiramidal adverse effects with the concomitant use of serotonin selective reuptake inhibitors].
    Revista medica de Chile, 2011, Volume: 139, Issue:11

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors

2011